Nil HOCAOĞLU, Serap MICILI CİLAKER, Şule KALKAN, Nergis MURAT, Burç AYDIN, Bekir Uğur ERGÜR

Correlation between Amitriptyline-Induced Cardiotoxic Effects and Cardiac S100b Protein in Isolated Rat Hearts

Background: Amitriptyline is an important cause of mortality due to its cardiovascular toxicity. Aims: To investigate the changes in levels of cardiac S100b protein on amitriptyline-induced cardiotoxicity and also to examine the correlation between amitriptyline-induced cardiotoxic effects and cardiac S100b protein in an isolated rat heart model. Study Design: Animal experimentation, isolated heart model. Methods: After a stabilization period, isolated hearts were randomized to two groups (n=5 and n=7). In the control group, isolated hearts were subjected to an infusion of 5% dextrose for 60 minutes. In the amitriptyline group, 5.5×10-5 M amitriptyline was infused for 60 minutes to achieve amitriptyline toxicity. After the infusion period, heart tissues were removed for histological examination. Results: In comparison to control treatment, amitriptyline infusion decreased left ventricular developed pressure (LVDP), dp/dtmax and heart rate (HR) and significantly prolonged QRS duration (p

PDF

___

Thanacoody HK, Thomas SH. Tricyclic antidepressant poi- soning: cardiovascular toxicity. Toxicol Rev 2005;24:205-14. [CrossRef]
Pimentel L, Trommer L. Cyclic antidepressant overdoses. Emerg Med Clin North Am 1994;12:533-47.
Shannon M, Liebelt EL. Toxicology reviews: Targeted mana- gement strategies for cardiovascular toxicity from tricyclic an- tidepressant overdose: The pivotal role for alkalinization and sodium loading. Pediatr Emerg Care 1998;14:293-8. [CrossRef]
Gürsoy M, Büyükuysal RL. Mechanism of S100b release from rat cortical slices determined under basal and stimulated condi- tions. Neurochem Res 2010;35:429-36. [CrossRef]
Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-68. [CrossRef]
Kahn HJ, Baumal R, Van Eldik LJ, Dunn RJ, Marks A. Immu- noreactivity of S100 beta in heart, skeletal muscle, and kidney in chronic lung disease: possible induction by cAMP. Mod Pathol 1991;4:698-701.
Tsoporis JN, Marks A, Kahn HJ, Butany JW, Liu PP, O'Hanlon D, et al. Inhibition of norepinephrine-induced cardiac hypertro- phy in S100beta transgenic mice. J Clin Invest 1998;102:1609- 16. [CrossRef]
Rothermundt M, Arolt V, Wiesmann M, Missler U, Peters M, Rudolf S, et al. S-100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord 2001;66:89- 93. [CrossRef]
Tsoporis JN, Mohammadzadeh F, Parker TG. S100B: a multi- functional role in cardiovascular pathophysiology. Amino Acids 2011;41:843-7. [CrossRef]
Mazzini GS, Schaf DV, Oliveira AR, Gonçalves CA, Belló- Klein A, Bordignon S, et al. The ischemic rat heart releases S100B. Life Sci 2005;77:882-9. [CrossRef]
Haring JH, Hagan A, Olson J, Rodgers B. Hippocampal sero- tonin levels influence the expression of S100 beta detected by immunocytochemistry. Brain Res 1993;631:119-23. [CrossRef]
Manev R, Uz T, Manev H. Fluoxetine increases the content of neurotrophic protein S100b in the rat hippocampus. Eur J Phar- macol 2001;420:R1-2. [CrossRef]
Manev H, Uz T, Manev R. Glia as a putative target for antide- pressant treatments. J Affect Disord 2003;75:59-64. [CrossRef]
Akhisaroglu M, Manev R, Akhisaroglu E, Uz T, Manev H. Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. Neuro Report 2003;14:1471-3. [CrossRef]
Manev R, Manev H. Could treatment with arundic acid (ONO- 2506) increase vulnerability for depression? Med Hypotheses 2006;67:1170-2. [CrossRef]
Manev H, Manev R. Olanzapine and S100 proteins. Neuropsy- chopharmacology 2006;31:2567. [CrossRef]
Hocaoglu N, Kalkan S, Buyukdeligoz M, Oransay K, Tuncok Y. Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects? Cardiovasc Toxicol 2012;12:115- 22. [CrossRef]
Akgun A, Kalkan S, Hocaoglu N, Gidener S, Tuncok Y. Effects of adenosine receptor antagonists on amitriptyline-induced QRS prolongation in isolated rat hearts. Clin Toxicol (Phila) 2008;46:677-85. [CrossRef]
Akgun Arici MA, Kalkan S, Demir O, Hocaoglu Aksay N, Gidener S, Tuncok Y. Does adenosine A(1) receptor stimulation causes QRS prolongation by blocking beta adrenergic recep- tors in amitriptyline poisoning? Toxicol Lett 2009;186:130-8. [CrossRef]
Micili SC, Goker A, Sayin O, Akokay P, Ergur BU. The effect of lipoic acid on wound healing in a full thickness uterine injury model in rats. J Mol Hist 2013;4:339-45. [CrossRef]
Tuzun F, Gencpınar P, Ozbal S, Dilek M, Ergur BU, Duman N, et al. Neuroprotective effect of neotrofin in a neonatal rat model of periventricular leukomalacia. Neurosci Lett 2012;520:6-10. [CrossRef]
Olgun H, Yildirim ZK, Karacan M, Ceviz N. Clinical, electro- cardiographic, and laboratory findings in children with ami- triptyline intoxication. Pediatr Emerg Care 2009;25:170-3. [CrossRef]
Buckley NA, Chevalier S, Leditschke IA, O'Connell DL, Leitch J, Pond SM. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Crit Care 2003;7:R101-7. [CrossRef]
van Boven WJ, Morariu A, Salzberg SP, Gerritsen WB, Waan- ders FG, Korse TC, et al. Impact of different surgical strategies on perioperative protein S100? release in elderly patients un- dergoing coronary artery bypass grafting. Innovations (Phila) 2013;8:230-6. [CrossRef]
Di Legge S, Di Piero V, Di Stani F, Perna R, Gattuso R, Reale MG, et al. Carotid endarterectomy and gliofibrillar S100b protein release. Neurol Sci 2003;24:351-6. [CrossRef]
Tsoporis JN, Izhar S, Leong-Poi H, Desjardins JF, Huttunen HJ, Parker TG. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction. Circ Res 2010;106:93-101. [CrossRef]